Coronavirus: BioNTech third shot offers ‘significantly higher’ immunity boost for Sinovac recipients with low antibody levels, Hong Kong researchers find

Nov 4, 2021 | INVESTING

Sinovac Covid-19 vaccine recipients with low antibody levels will get a “significantly higher” boost to immunity from a third dose of the BioNTech jab than by sticking with their original choice of brand, according to research by two Hong Kong universities published on Thursday.The first local head-to-head study of its kind also found that the German-manufactured BioNTech vaccine generated markedly higher levels of “specific neutralising antibodies” against the more infectious Delta variant…

Read More

Pin It on Pinterest